Navigation Links
First finding of a metabolite in 1 sex only
Date:8/21/2007

Researchers at the University of Illinois at Chicago have discovered a chemical compound in male blue crabs that is not present in females -- the first time in any species that an entire enzyme system has been found to be activated in only one sex.

The research, performed using nuclear magnetic resonance, was published online Aug. 22 in PLoS ONE, the peer-reviewed, open-access resource from the Public Library of Science.

Although hormone level differences are generally accepted as the primary cause of variation between the sexes in animal and human development, the existence of a sex-specific metabolite is a previously unrecognized and potentially significant biochemical phenomenon, according to Robert Kleps, director of the UIC Research Resource Center NMR Lab and lead author of the study.

"It's possible to speculate that the presence or absence of a sex-specific metabolite might affect an animal's development, anatomy and biochemistry," Kleps said. Differences between the sexes such as susceptibility to heart disease or average life span might be due to the presence or absence of a metabolite, he said.

Now that the existence of a sex-specific metabolite has been proved for one animal, Kleps says researchers might review metabolic studies in other animals, including humans, to look for the presence of a sex-specific metabolite that might have escaped notice in the variation among individuals.

Using primarily phosphorus-31 NMR, with the capability of analyzing whole tissue, Kleps observed an unusual signal in the gill tissue of male blue crabs that was absent in females.

NMR can be measured in the nuclei of certain isotopes, including hydrogen-1, carbon-13 and phosphorus-31, whose atoms resonate at characteristic frequencies in a magnetic field. The exact frequency is slightly changed by the atom's chemical micro-environment within a particular molecule.

The researchers found in male gill tissue an atom of P-31 with a signature "chemical shift," indicating the presence of a unique, unidentified phosphorus compound.

They then isolated and analyzed the phosphorus compound, identifying it as 2-aminoethyl phosphonate, an uncommon but well-documented metabolite. AEP is not known to be a hormone.

The researchers tested gill tissue from crabs harvested in six different years from the Chesapeake Bay and the gulf coast of Florida. Specimens from each region produced similar results, confirming that the presence of AEP in males and absence in females is the norm for blue crabs.

But, Kleps said, it was still not possible to rule out that the difference between the sexes was due to a difference in their diet. Fortunately, while writing the first draft of the paper, Kleps happened to read that a rare gynandromorphic blue crab -- one half male, one half female -- had been captured by Romuald Lipcius of the Virginia Institute of Marine Science at the College of William & Mary.

The rare gynandromorph is divided down the middle, with a characteristic blue male claw and a female red claw. The underside of the crab is also visibly divided into male and female halves. After the crab died, Lipcius sent Kleps gill tissue from each side for analysis. The measured levels of AEP from the male and female gills provided additional evidence that AEP is a sex-specific compound.

"Since both sides of this strange crab have, of necessity, shared a diet and environment, we had completely independent confirmation of the sex-specific nature of this metabolite," said Kleps.

"That blue crabs have this sex-specific compound may be a fluke, or it might represent a common but overlooked process in animal development," he said.


'/>"/>

Contact: Jeanne Galatzer-Levy
jgala@uic.edu
312-996-1583
University of Illinois at Chicago
Source:Eurekalert

Related biology news :

1. A genes first kiss sets off that affair known as puberty
2. Timing is everything: First step in protein building revealed
3. Emory Eye Center Implants Its First Retinal Chips In Patients With Retinitis Pigmentosa
4. First atlas of key brain genes could speed research on cancer, neurological diseases
5. First-ever Compounds To Target Only Metastatic Cells Are Highly Effective Against Breast, Prostate, And Colon Cancers
6. NYCs First Rapid HIV Drug-resistant AIDS Case Prompts Call to Step Up HIV Prevention
7. First real-time view of developing neurons reveals surprises, say Stanford researchers
8. Love at first smell
9. Worlds largest rainforest drying experiment completes first phase
10. PCRM develops worlds first cruelty-free insulin assay
11. Breast-Cancer Risk Linked to Exposure to Traffic Emissions at Menarche, First Birth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
(Date:3/29/2016)... LegacyXChange, Inc. (OTC: LEGX ... Protect are pleased to announce our successful effort to ... of writing instruments, ensuring athletes signatures against counterfeiting and ... athletes on LegacyXChange will be assured of ongoing proof ... Bill Bollander , CEO states, "By inserting ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 23, 2016  Blueprint Bio, a company dedicated to ... medical community, has closed its Series A funding round, ... "We have received a commitment from Forentis ... need to meet our current goals," stated Matthew ... runway to complete validation on the current projects in ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... at the Pennsylvania Convention Center and will showcase its product’s latest features from ... also be presenting a scientific poster on Disrupting Clinical Trials in The Cloud ...
(Date:6/23/2016)... -- Amgen (NASDAQ: AMGN ) today announced a ... sciences incubator to accelerate the development of new therapies ... QB3@953 was created to help high-potential life science and ... stage organizations - access to laboratory infrastructure. ... "Amgen Golden Ticket" awards, providing each winner with one ...
(Date:6/22/2016)... , June 22, 2016 Research and ... Global Markets" report to their offering. ... billion in 2014 from $29.3 billion in 2013. The market is ... of 13.8% from 2015 to 2020, increasing from $50.6 billion in ... projected product forecasts during the forecast period (2015 to 2020) are ...
Breaking Biology Technology: